Designing ECM-Inspired Peptide Biomaterials for Regenerative Medicine
Designing ECM-Inspired Peptide Biomaterials for Regenerative Medicine
批准号:
7535620
负责人:
Joel H Collier
金额:
$21.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2009-07-31
关键词:
AddressAffectAmino Acid SequenceAmino Acid SubstitutionAmino AcidsArchitectureBehaviorBiocompatible MaterialsBiomedical EngineeringBlood ClotBlood coagulationCellsCircular Dichroism SpectroscopyClassCoiled-Coil DomainCollectionComplexDataDevelopmentDrug ControlsElectrostaticsEmerging TechnologiesEngineeringEvaluationExtracellular MatrixEyeFaceFamilyFibrinFundingFutureGoalsHealthHumanImmune responseImmune systemImmunologicsImmunologistImmunologyIn VitroIndividualLeadMedicalModificationMolecularMusNatural regenerationOutcomes ResearchPeptidesPropertyProteinsPublic HealthRangeRegenerative MedicineResearchResearch PersonnelRiskRouteSeriesStructural BiologistStructureSystemTestingTissue EngineeringTo specifyTranslationsWorkWound Healinganalytical ultracentrifugationbasecrosslinkdesignimmunogenicimmunogenicityimmunoreactivityin vivoinnovationmultidisciplinarynanostructurednovelpeptidomimeticspre-clinicalprogramsreceptorreconstructionresponsescaffoldself assemblysoft tissuestructural biologytissue glueingtranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: The long-term goal of this research is to engineer new biomaterials formulated from self-
assembling peptides or peptidomimetics to produce synthetic extracellular matrices (ECMs) useful for tissue
repair or regeneration. Such approaches will enable new therapies for periodontal wound healing, facial soft
tissue reconstruction, and other applications in regenerative medicine and tissue engineering. As scaffolds
for these therapies, peptide-based biomaterials possess advanced properties such as tunable bioactivity,
highly controllable fibrillar architectures, and complex presentation of many different peptides to provide
multiple receptor-specific interactions between cells and the material. A critical issue, however, revolves
around designing these scaffolds so that they are well-tolerated immuno|ogically, because peptide
immunogenicity can be significantly enhanced by multimerization or assembly. To address the dual issues
of designing self-assembling peptide biomaterials from native peptides likely to be tolerated while
concurrently understanding how peptide designs impact immunoreactivity, the research is subdivided into
the following two aims: Aim 1) Design minimally modified fibrin-inspired oligomerization domains by
understanding the impact of amino acid tailoring on folding and multimerization; Aim 2) Determine the
immunogenic tolerability of peptide tailoring. These aims will be accomplished by a collaborative team of
biomedical engineers, structural biologists, and immunologists by designing a novel series of multimerizing
peptides inspired by the protein fibrin, analyzing peptide folding/oligomerization behavior with circular
dichroism spectroscopy and analytical ultracentrifugation, and investigating the humoral and cellular
immunologic response to the designed peptides in mice. The outcomes of this research include the design
of minimally-immunogenic peptides that fold into useful oligomerizing structures and an understanding of
how peptide design affects immunoreactivity within these self-assembling systems. Thus, this research will
enable future studies in which biomaterials produced from these designed peptide building blocks will be
investigated as new scaffolds for regenerative medicine. Relevance: This research is relevant to the public
health because it provides new materials for reconstructing damaged or diseased soft tissues. Also, the
research will broaden the understanding of how this class of materials interacts with the immune system.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.biomaterials.2010.07.068
发表时间:
2010-11
期刊:
BIOMATERIALS
影响因子:
14
作者:
[Rudra, Jai S., Tripathi, Pulak K., Hildeman, David A., Jung, Jangwook P., Collier, Joel H.]
通讯作者:
Collier, Joel H.
DOI:
10.1002/bip.21326
发表时间:
2010
期刊:
BIOPOLYMERS
影响因子:
2.9
作者:
[Jung, Jangwook P., Gasiorowski, Joshua Z., Collier, Joel H.]
通讯作者:
Collier, Joel H.
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
-
批准号:10538835
-
项目类别:
-
资助金额:$56.15万
-
财政年份:2022
-
负责人:Joel H Collier
-
依托单位:
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
-
批准号:10631187
-
项目类别:
-
资助金额:$54.95万
-
财政年份:2022
-
负责人:Joel H Collier
-
依托单位:
Engineered immunotherapies neutralizing interleukin-22 binding protein
-
批准号:10688059
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2022
-
负责人:Joel H Collier
-
依托单位:
Engineered immunotherapies neutralizing interleukin-22 binding protein
-
批准号:10538770
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2022
-
负责人:Joel H Collier
-
依托单位:
Sublingual Supramolecular Vaccines and Immunotherapies
-
批准号:10671694
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2021
-
负责人:Joel H Collier
-
依托单位:
Supramolecular peptide immunotherapies for peanut allergy
-
批准号:10416075
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2021
-
负责人:Joel H Collier
-
依托单位:
Supramolecular peptide immunotherapies for peanut allergy
-
批准号:10317230
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2021
-
负责人:Joel H Collier
-
依托单位:
Sublingual Supramolecular Vaccines and Immunotherapies
-
批准号:10390493
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2021
-
负责人:Joel H Collier
-
依托单位:
Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
-
批准号:10571804
-
项目类别:
-
资助金额:$63.3万
-
财政年份:2020
-
负责人:Joel H Collier
-
依托单位:
Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
-
批准号:10343752
-
项目类别:
-
资助金额:$63.94万
-
财政年份:2020
-
负责人:Joel H Collier
-
依托单位:
Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
-
批准号:10117193
-
项目类别:
-
资助金额:$64.58万
-
财政年份:2020
-
负责人:Joel H Collier
-
依托单位:
Supramolecular pediatric HIV vaccine design
-
批准号:10341039
-
项目类别:
-
资助金额:$76.76万
-
财政年份:2019
-
负责人:Joel H Collier
-
依托单位:
Supramolecular pediatric HIV vaccine design
-
批准号:9752754
-
项目类别:
-
资助金额:$79.32万
-
财政年份:2019
-
负责人:Joel H Collier
-
依托单位:
Supramolecular pediatric HIV vaccine design
-
批准号:9902327
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2019
-
负责人:Joel H Collier
-
依托单位:
Supramolecular pediatric HIV vaccine design
-
批准号:10390375
-
项目类别:
-
资助金额:$76.14万
-
财政年份:2019
-
负责人:Joel H Collier
-
依托单位:
Supramolecular matrix materials for prostate cancer cell biology
-
批准号:9306789
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2016
-
负责人:Joel H Collier
-
依托单位:
Modular Biomaterials for Targeted Anti-Cytokine Immunotherapies
-
批准号:8682383
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2014
-
负责人:Joel H Collier
-
依托单位:
Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
-
批准号:10164780
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2009
-
负责人:Joel H Collier
-
依托单位:
Modular Self-Assembled Coatings for Biomaterials
-
批准号:7697738
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2009
-
负责人:Joel H Collier
-
依托单位:
Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
-
批准号:8739284
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2009
-
负责人:Joel H Collier
-
依托单位:
海外基金